Hereditary hemorrhagic telangiectasia
Supplements studied for hereditary hemorrhagic telangiectasia.
Overview
N-Acetyl Cysteine (NAC) is the sole indexed supplement for hereditary hemorrhagic telangiectasia (1 study; WA 40; low effect size, low evidence, low trust). HHT is characterized by recurrent nosebleeds, which was the main outcome in the available trial.
One small study found taking NAC three times daily for 12 weeks lowered daytime nosebleeds but did not affect nosebleeds at night. Because evidence comes from a single low-rated trial, it remains uncertain whether NAC helps with HHT-related bleeding. See the evidence review below for the trial summary.
Effect graph
Subscribe to view effect graphs
Interactive visualisations of ranked conditions and clinical benefit with purchase guidance.
Already a subscriber? Sign in
Relevant supplements heatmap
Relevant supplements sorted by DEX Score.
Subscribe to view effect heatmaps
See effect size, evidence strength, and trust at a glance for every condition.
Already a subscriber? Sign in
SupplementDEX Database
1 supplement for rated at least stars. All purchase bands. No minimum star filter.
Subscribe to access the SupplementDEX Database
Read this and 2,600+ other evidence reviews on our practitioner plan.
Already a subscriber? Sign in
Evidence visualised
Subscribe to view condition evidence
Visual summaries of supplement evidence ranked by condition.
Already a subscriber? Sign in